Company News & Press
Metabolon will perform metabolomics on study participants as part of the five-year longitudinal study to improve risk assessment of complications of obesity, supporting greater understanding in patient stratification for the right treatment depending on metabolic profiles.
Metabolomic insights will support the leading science and technology company in advancement of its drug early development programs across therapeutic areas.
22 June 2020
OMNImet™·GUT expands access to critical metabolomic analysis with development of in-home fecal collection device – the first device for in-home collection and ambient-temperature storage and shipping of fecal samples for metabolomics, to the research market.
Find Us at These Events
6 October 2020
Join over 800 scientific leaders at the flagship Cell Series UK, connecting regenerative medicine and bioprocessing experts to transform cell research and therapies.
21 September 2020
Visit us at booth 610 Connect with 2000+ global scientists, engineers and executives working across the entire spectrum of biopharmaceutical development and production.
IGES is the International Genetic Epidemiology Society, a scientific society concerned with “the study of genetic components in complex biological phenomena” according to James V. Neel, the founding President of the Society. The successful mapping of the human genome will greatly facilitate the study of health and disease in a manner that integrates both host and environmental factors.
27 May 2020
Join Metabolon’s Patricia Sheridan, Ph.D., Senior Study Director, Discovery & Translational Sciences, for a conversation with Dr. Heath on May 27th at 11:00 am EDT/13:00 CEST. They will be discussing some of the current work that ISB is doing to explore COVID-19 infections and how metabolomics can be used to understand the pathophysiology of the infection.